Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography
β Scribed by Dr. K. L. Leenders; R. S. J. Frackowiak; N. Quinn; C. D. Marsden
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 549 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
A 48-year-old man with typical Huntington's disease was investigated with computed tomography (CT) and positron emission tomography. Regional cerebral blood flow, oxygen extraction, oxygen and glucose utiIisation, L-Dopa uptake, and dopamine (D2) receptor binding were measured using several positronlabelled tracers. CT showed slight atrophy of the head of caudate but no cortical atrophy, although distinct frontal lobe dysfunction was present on psychometric testing. Oxygen and glucose metabolism and cerebral blood flow were decreased in the striata and to a lesser extent in frontal cortex. Cerebral blood flow was in the low normal range throughout the remainder of the brain. A normal metabolic ratio was found in all regions, since the changes in glucose utilisation paralleled those in oxygen consumption. The capacity of the striatum to store dopamine as assessed by L-[**F]-fluorodopa uptake was normal, but dopamine (D2) receptor binding was decreased when compared to normal subjects.
π SIMILAR VOLUMES
There is increasing evidence for familial aggregation in Parkinson's disease (PD). It is possible that some asymptomatic relatives of I'D patients have subclinical nigral Lewy body pathology and their identification could help determine the true prevalence of the disease. We used 18F-dopa positron e
Animal studies and results from 13N-ammonia positron emission tomography (PET) in patients with cirrhosis and minimal hepatic encephalopathy suggest that a disturbed brain ammonia metabolism plays a pivotal role in the pathogenesis of hepatic encephalopathy (HE). We studied brain ammonia kinetics in
## Abstract Both somatosensory evoked potentials (SEP) and striatal glucose consumption (rCMRGlc) measured by positron emission tomography (PET) have been reported to be abnormal early in the course of Huntington's disease (HD). To compare their diagnostic value, SEP and rCMRGlc were measured in a
The first successful in vivo imaging of monoamine vesicular transporters in the living primate brain is described, using [llcltetrabenazine (["ClTBZ) and Positron Emission Tomography (PET). Radioligand uptake into brain is rapid, and at short time periods (10-30 minutes) the higher uptake and retent